These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6808966)

  • 1. [Protective antigens of the swine erysipelas bacterium (Erysipelothrix rhusiopathiae. 2. Further characterization of the protective antigen].
    Rothe F
    Arch Exp Veterinarmed; 1982; 36(2):255-67. PubMed ID: 6808966
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective antigens of the swine erysipelas bacterium (Erysipelothrix rhusiopathiae. 1. Specific demonstration of the protective antigen].
    Rothe F
    Arch Exp Veterinarmed; 1982; 36(2):243-53. PubMed ID: 6808965
    [No Abstract]   [Full Text] [Related]  

  • 3. Specificity in response of vaccinated swine and mice to challenge exposure with strains of Erysipelothrix rhusiopathiae of various serotypes.
    Wood RL
    Am J Vet Res; 1979 Jun; 40(6):795-801. PubMed ID: 112891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection.
    Cheun HI; Kawamoto K; Hiramatsu M; Tamaoki H; Shirahata T; Igimi S; Makino SI
    J Appl Microbiol; 2004; 96(6):1347-53. PubMed ID: 15139928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and identification of a novel candidate vaccine protein through systematic analysis of extracellular proteins of Erysipelothrix rhusiopathiae.
    Shi F; Ogawa Y; Sano A; Harada T; Hirota J; Eguchi M; Oishi E; Shimoji Y
    Infect Immun; 2013 Dec; 81(12):4333-40. PubMed ID: 24019408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of sera from swine immunized with different fractions from broth culture of an attenuated strain of Erysipelothrix rhusiopathiae.
    Sawada T; Takahashi T; Tamura Y
    Nihon Juigaku Zasshi; 1987 Feb; 49(1):37-42. PubMed ID: 3573490
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protective medium for the lyophilization of a live vaccine against swine erysipelas--VR2].
    Khristova Kh; Ninov NV; Dilovska Kh
    Vet Med Nauki; 1984; 21(7-8):57-61. PubMed ID: 6506460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative effectiveness of vaccines against erysipelas].
    Koniaev MT; Shcherbinin VK
    Veterinariia; 1980 Mar; (3):33-4. PubMed ID: 7395054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunity of native SpaA and recombinant SpaA-N against Erysipelothrix rhusiopathiae infection in mice].
    Nazierbieke W; Zhang L; He C; Peng Q; Borrathybay E
    Wei Sheng Wu Xue Bao; 2010 Mar; 50(3):367-72. PubMed ID: 20499642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross protection of mice and swine given live-organism vaccine against challenge exposure with strains of Erysipelothrix rhusiopathiae representing ten serovars.
    Sawada T; Takahashi T
    Am J Vet Res; 1987 Jan; 48(1):81-4. PubMed ID: 3826847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aerogenic immunization against swine erysipelas with Spirovak erysipelas vaccine "Dessau"].
    Urbaneck D; Stöhr P; Michael-Meese M
    Arch Exp Veterinarmed; 1980; 34(1):51-4. PubMed ID: 7416893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antibiotics on the immune system of animals. III. Experiments in pgis immunized with live and inactivated swine erysipelas vaccines.
    Tu TD
    Acta Vet Acad Sci Hung; 1981; 28(3):317-31. PubMed ID: 7258020
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of Met-203 type spaA variant in Erysipelothrix rhusiopathiae isolates and the efficacy of swine erysipelas vaccines in Japan.
    Uchiyama M; Yamamoto K; Ochiai M; Yamamoto T; Hirano F; Imamura S; Nagai H; Ohishi K; Horiuchi N; Kijima M
    Biologicals; 2014 Mar; 42(2):109-13. PubMed ID: 24405986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vaccination against swine erysipelas--field experiences in Croatia.
    Hoffmann CR; Bilkei G
    Dtsch Tierarztl Wochenschr; 2006 Jan; 113(1):13-5. PubMed ID: 16475549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humane endpoints in the efficacy testing of swine erysipelas vaccines.
    Johannes S; Hartinger J; Hendriksen CF; Morton DB; Cussler K
    ALTEX; 2003; 20(1):11-5. PubMed ID: 12579350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serological, chemical and immunological studies of the swine erysipelas bacterium. l. Differentiation of Erysipelothrix insidiosa type B by means of precipitation from hydrochloric acid extracts].
    Erler W
    Arch Exp Veterinarmed; 1968; 22(6):1125-38. PubMed ID: 5754074
    [No Abstract]   [Full Text] [Related]  

  • 17. Erysipelas immunizing product review.
    Bairey MH; Vogel JH
    Proc Annu Meet U S Anim Health Assoc; 1973; (77):340-4. PubMed ID: 4534722
    [No Abstract]   [Full Text] [Related]  

  • 18. [Local antigen persistence and chronicity of experimental erysipelas polyarthritis].
    Denecke R; Trautwein G
    Berl Munch Tierarztl Wochenschr; 1986 Jun; 99(6):200-8. PubMed ID: 3741366
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterisation of Erysipelothrix rhusiopathiae isolates from pigs associated with vaccine breakdowns.
    Eamens GJ; Forbes WA; Djordjevic SP
    Vet Microbiol; 2006 Jul; 115(4):329-38. PubMed ID: 16621346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a monoclonal antibody for in vitro potency testing of erysipelas bacterins.
    Henderson LM; Jenkins PS; Scheevel KF; Walden DM
    Dev Biol Stand; 1996; 86():334. PubMed ID: 8785974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.